Robuta

https://www.aidsmap.com/news/oct-2016/new-long-acting-fusion-inhibitor-albuvirtide-plus-boosted-protease-inibitor-matches New long-acting fusion inhibitor albuvirtide plus boosted protease inibitor matches standard... A new fusion inhibitor, albuvirtide, under development in China, combined with a boosted protease inhibitor, proved just as effective as a triple regimen of... new long fusion inhibitor https://www.ncbi.nlm.nih.gov/Structure/pdb/6EAK 6EAK: CRYSTAL STRUCTURE OF FUSION INHIBITOR JNJ-2408068 IN COMPLEX WITH HUMAN RESPIRATORY SYNCYTIAL... Fusion glycoprotein F02-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC... https://www.researchandmarkets.com/reports/6150916/fusion-protein-vegf-inhibitor-market-global Fusion Protein VEGF Inhibitor Market - Global Forecast 2025-2030 This report features 6 companies, including Bayer Aktiengesellschaft, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd, Chengdu Kanghong... fusion protein vegf inhibitor market global https://www.ncbi.nlm.nih.gov/Structure/pdb/8XNE 8XNE: Crystal structure of measles virus fusion inhibitor M1 complexed with F protein HR1 (HR1-42)... Fusion glycoprotein F1MAGNESIUM ION https://www.ncbi.nlm.nih.gov/Structure/pdb/2L6T 2L6T: Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide https://www.jci.org/articles/view/123089/figure/2 JCI - Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion https://www.ncbi.nlm.nih.gov/Structure/pdb/6EAD 6EAD: CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE... Fusion glycoprotein F02-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID2-acetamido-2-deoxy-beta-D-glucopyranoseSULFATE ION respiratory syncytial virus crystal structure https://www.mdpi.com/1999-4915/14/3/597 A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2... The prolonged duration of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has resulted in the continuous emergence of variants of... https://www.jci.org/articles/view/123089/figure/3 JCI - Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion